| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
BioNTech SE
13G/A
BNTX · 09075V102
Amended
by Ugur Sahin
on 5/15/2026
|
17.6% |
5/13/2025
Event 3/31/2025
|
||||
| Medine GmbH | 16.7% | |||||
| Prof. Ugur Sahin, M.D. | 17.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.